AEZS Key Stats
| Income Statement | |
| Revenue TTM | 33.66M |
| Revenue Quarterly YoY Growth | -24.41% |
| EPS Diluted TTM | -1.057 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -20.41M |
| Profitability | |
| Gross Profit Margin Quarterly | 21.54% |
| Profit Margin Quarterly | -72.78% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 53.19M |
| Enterprise Value | 13.67M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | |
| Free Cash Flow | -8.876M |
| Return on Equity | |
AEZS News
- Smaller Companies With Potential For Big Returns May 16
- Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor C... May 15
- Tackling Cancer: Endometrial Cancer's Biggest Current & Upcoming Players May 11
- Disappointing 1Q Earnings for IART May 10
- Disappointing 1Q Earnings for IART - Analyst Blog Zacks May 10
- Aeterna Zentaris Announces Election of Directors at its Annual Meeting of Shareh... May 8
- Æterna Zentaris Management Discusses Q1 2013 Results - Earnings Call Transcript Seeking Alpha May 8
- Aeterna Zentaris Reports First Quarter 2013 Financial and Operating Results CNW Group May 7
- May 1, 2013 Aeterna Zentaris to Announce First Quarter 2013 Financial and Operat... May 1
- Aeterna Zentaris to Announce First Quarter 2013 Financial and Operating Results ... May 1
AEZS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AEterna Zentaris is down 23.08% over the last year vs S&P 500 Total Return up 30.71%, Alkermes up 93.00%, and Agenus down 22.02%.
AEZS Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these AEZS related companies
Pro Ratings for AEZS
Pro Report PDF for AEZS
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download AEZS Pro Report PDF
Pro Strategies Featuring AEZS
Did AEterna Zentaris make it into our Pro Portfolio Strategies?
AEZS Profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Other AEZS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AEZS | 2.10 | +0.04 | +1.94% | 53.19M |
